Article
<i>Chryseobacterium indologenes</i> mediates resistance to osimertinib by activating the IGF1R pathway in EGFR-mutant lung adenocarcinoma
2025-10-09
Abstract excerpt
<h4>Introduction</h4> Lung cancers harboring sensitizing epidermal growth factor receptor (EGFR) mutations typically exhibit an initial response to osimertinib; however, the development of resistance is inevitable, and there are currently no approved targeted therapies available once resistance emerges. Accumulating evidence indicates that intra-tumoral bacteria can influence tumor biology and contribute to thera...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 20e97470-52da-585a-bf63-7286c47f27e9
- DOI
- 10.1101/2025.10.08.681060
